Aphrodisiac effect of VAJI-12 drug on Erectile dysfunction with or without premature ejaculatio
Phase 2
Completed
- Conditions
- Health Condition 1: null- 100 Male patients with erectile dysfunction and premature ejaculation, which fulfilling the diagnostic criteria of Erectile Dysfunction and Premature ejaculation will be selected for the studyHealth Condition 2: N529- Male erectile dysfunction, unspecifiedHealth Condition 3: N529- Male erectile dysfunction, unspecified
- Registration Number
- CTRI/2019/04/018642
- Lead Sponsor
- niversity Junior Research Fellowship
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Male married patients suffering from Klaibya (ED) and Premature ejaculation
Exclusion Criteria
Age below 21 and above 50 years, Unmarried patients, Patients suffering from STD, Carcinoma, AIDS, congenital abnormalities of genital organs, other disease like Phimosis, Ulceration, Hydrocele, Spinal cord lesions, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of Research Drug will be assessed after 90 days duration with 3 followupsTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method ATimepoint: NA